Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mesoblast Ltd

+ Add to Watchlist

MBLTY:US

14.1900 USD 0.2100 1.46%

As of 20:10:02 ET on 03/30/2015.

Snapshot for Mesoblast Ltd (MBLTY)

Open: 14.1900 Day's Range: 14.1900 - 14.1900 Volume: 350
Previous Close: 14.4000 52wk Range: 13.9280 - 27.0100 1-Yr Rtn: -44.14%

Stock Chart for MBLTY

No chart data available.
  • MBLTY:US 14.1900
  • 1D
  • 1M
  • 1Y
14.4000
Interactive MBLTY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MBLTY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -1.6340
Est. PEG Ratio -
Market Cap (M USD) 920.76
Shares Outstanding (M) 64.89
30 Day Average Volume 1,243
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MBLTY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for MBLTY

Mesoblast Ltd., is a biotechnology company. The Company develops treatments for orthopaedic conditions, including the commercialisation of adult stem cells to regenerate, repair bone. and cartilage.

Silviu ItescuChief Executive OfficerPaul HodgkinsonChief Financial Officer
James T Ryaby "Jim"VP:Research & Clinical AffairsJohn McMannisExec VP:Manufacturing
More Company Profile & Key Executives for MBLTY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil